Portugal’s Hovione builds spray drying capacity in US and Ireland
Spray drying involves converting pharmaceutical liquid solutions into tiny droplets that are rapidly dried with hot gases such as nitrogen. This turns medicinal products into...
Phase 3 success for AstraZeneca prostate drug
AstraZeneca has reported positive results from the CAPItello-281 phase 3 trial, which evaluated Truqap (capivasertib) in combination with Johnson & Johnson’s Zytiga (abiraterone) and androgen...
We’ve upgraded Outsourcing Pharma to give you more of what you love
What’s new at leading trade publication Outsourcing Pharma...
Adragos Pharma snaps up Baccinex to expand CDMO network
Founded in Munich in 2020, Adragos’ global manufacturing sites were acquired from other players including Haupt Pharma Livron, LAW Pharma, Sanofi and Fresenius Kabi. They...
Decentralized clinical trials market expected to grow to $25BN
According to a recent report by Business Research Insights, the total size of the global decentralized clinical trials market was $7.14 billion in 2023, a...
How eCOA/ePRO is transforming clinical trials
eCOA and ePRO (electronic patient-reported outcome) technology are transforming clinical trials, offering streamlined processes for patients, sites, and sponsors. In this Q&A, Steve shares how...
C Ray Therapeutics $100M to improve RDC technology platform
C Ray Therapeutics has announced the completion of a series A+ financing round, which has exceeded the $100 million mark. The round was co-led by...
Promising phase 2 results for Eli Lilly’s Muvalaplin
Yesterday, Eli Lilly and Company revealed promising Phase 2 results for its investigational small molecule drug, Muvalaplin, against cardiovascular events. The drug met its primary...
Chemistry passion to industry leadership
Now the Global market development manager at Phenomenex, she thrives on connecting insights with solutions, all while channeling the wisdom of her science-loving microbiologist father....
From lab to leading biopharma innovation
Now leading the Biopharma product management team at Phenomenex, she brings a problem-solving mindset honed by a love of forensic science and analytical chemistry. Her...
Samsung Biologics and European pharma company enter major manufacturing deal
The global contract development and manufacturing organization (CDMO), Samsung Biologics, announced this week that it has entered into a collaboration with an undisclosed European pharmaceutical...
Pfizer’s HYMPAVZI wins EU approval for hemophilia A and B care
The US big pharma company Pfizer has been granted marketing authorization for its hemophilia A and B treatment, HYMPAVZI (marstacimab), by the European Commission based...
Drug-free pain relief for knee osteoarthritis
Sameer Sabir, CEO and co-founder of Brixton Biosciences, aims to revolutionize pain management. With Neural Ice, the company’s groundbreaking drug-free therapy, Brixton aims to offer...
Icotrokinra ‘best in class oral therapeutic for plaque psoriasis’
The phase 3 ICONIC-LEAD study showed that icotrokinra, a peptide drug that blocks the interleukin (IL)-23 receptor, was able to induce significant clearance of psoriatic...
Icotrokinra ‘best in class oral therapeutic for plaque psoriasis’
The phase 3 ICONIC-LEAD study showed that icotrokinra, a peptide drug that blocks the interleukin (IL)-23 receptor, was able to induce significant clearance of psoriatic...
Pfizer’s HYMPAVZI wins EU approval for hemophilia A and B care
The US big pharma company Pfizer has been granted marketing authorization for its hemophilia A and B treatment, HYMPAVZI (marstacimab), by the European Commission based...
C Ray Therapeutics $100M to improve RDC technology platform
C Ray Therapeutics has announced the completion of a series A+ financing round, which has exceeded the $100 million mark. The round was co-led by...
Promising phase 2 results for Eli Lilly’s Muvalaplin
Yesterday, Eli Lilly and Company revealed promising Phase 2 results for its investigational small molecule drug, Muvalaplin, against cardiovascular events. The drug met its primary...
Coronado’s CSO champions data-driven innovation in clinical trials
At the helm of Coronado’s scientific strategy, Professor Visser-Rogers envisions a data-driven future powered by innovative methodologies and emerging technologies. Her approach emphasizes not only...
Gifthealth partners with United Digestive
Gifthealth has announced a strategic partnership with United Digestive, a leading practice management organization for gastroenterology. This is to enhance patient access and improve preparation...